Finland· FI-REL-REL2767
Spasmo-Oxepam
A ambutonium mit psycholeptika product containing oxazepam + ambutonium bromide, registered in Finland by Haupt Pharma Münster GmbH.
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Oxazepam + Ambutonium bromide
- Manufacturer
- Haupt Pharma Münster GmbH
- Country
- Finland (FI)
- ATC code
- A03CA07
- ATC class
- Ambutonium mit Psycholeptika
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A03CA07
Ambutonium mit psycholeptika, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6973964-1f64-4bb1-8794-4a6e12a9a8e5 GET /v1/drugs/c6973964-1f64-4bb1-8794-4a6e12a9a8e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "3",
"form": "tabletti",
"route": null,
"ddd_unit": "ED",
"strength": null,
"atc_label": "ambutonium ja psyykenlääke",
"ma_number": "10275",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL2767",
"authorised_at": "1990-08-15"
}See everything about ambutonium mit psycholeptika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.